1,292 results on '"Noguchi, Shinzaburo"'
Search Results
52. Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients
53. Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing
54. C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis
55. PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
56. 2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission
57. Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial
58. ASO Author Reflections: Intraoperative Nomograms Based on One-Step Nucleic Acid Amplification
59. Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer
60. Gene expression signature of TP53 but not its mutation status predicts response to sequential paclitaxel and 5-FU/epirubicin/cyclophosphamide in human breast cancer
61. Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ
62. A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large‐scale, multicenter cohort study
63. Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2
64. Phase III randomized trial of toremifene versus tamoxifen for Japanese postmenopausal patients with early breast cancer
65. Lack of genomic rearrangements involving the aromatase gene CYP19A1 in breast cancer
66. Long-term follow-up results of breast cancer patients with sentinel lymph node biopsy using periareolar injection
67. Aesthetic utility of addition of nipple-areola recentralization to rotation flap according to nipple tumor distance for patients with lower-outer or upper-inner located breast cancers
68. Japanese contribution to the field of sentinel lymph node biopsy for breast cancer patients: introduction to invited articles
69. Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer
70. Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients
71. A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer
72. Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609
73. Comparison of the multigene panel test and OncoScan™ for the determination of HER2 amplification in breast cancer
74. Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference
75. Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients
76. 14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancers
77. Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results
78. MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide
79. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay
80. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients
81. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation
82. Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients
83. Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts
84. Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer
85. Sentinel lymph node biopsy before versus after neoadjuvant chemotherapy for breast cancer
86. Quantitative assessment of mammographic density and breast cancer risk for Japanese women
87. Topoisomerase IIalpha-positive and BRCA1-negative phenotype: Association with favorable response to epirubicin-based regimens for human breast cancers
88. Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers
89. Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breast
90. Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer
91. Predictive factors for anthracycline-based chemotherapy for human breast cancer
92. Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group
93. BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer
94. Breast cancer risk assessment for possible tailored screening for Japanese women
95. Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes
96. Incidence of joint symptoms and bone fractures in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole
97. Association of loss of BRCA1 expression with centrosome aberration in human breast cancer
98. Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis
99. Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial
100. Intraoperative Frozen Section Analysis of Sentinel Lymph Node in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.